Intended for healthcare professionals

CCBYNC Open access
Research

Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses

BMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d6333 (Published 31 October 2011) Cite this as: BMJ 2011;343:d6333

Article usage

Article metrics provide readers and authors with an indication of how often a specific article has been accessed month by month. It counts three formats - abstract/extract, full text and pdf. The page is updated each day.

Usage statistics: January 2018 to April 2024

Rendering graph...
AbstractFullPdf
Jan 20180586
Feb 20181584
Mar 201805112
Apr 20180545
May 201806015
Jun 20182555
Jul 201824436
Aug 201819012
Sep 20180563
Oct 201816410
Nov 2018111012
Dec 2018112218
Jan 201906621
Feb 201915712
Mar 201905315
Apr 201915614
May 20192458
Jun 201905820
Jul 20191548
Aug 201905811
Oct 201904510
Nov 20190409
Dec 20198305
Jan 20201434
Feb 20200518
Mar 20201375
May 202012412
Jun 202014311
Jul 20204387
Aug 202011233
Sep 20200275
Oct 202005812
Nov 20200456
Dec 202017712
Jan 20211428
Feb 202135220
Mar 20211203
Apr 202105211
May 202185912
Jun 202105118
Jul 202193617
Aug 20210259
Sep 202113711
Oct 202136021
Nov 202105226
Dec 202118410
Jan 20220566
Feb 202205410
Mar 202201029
Apr 202227312
May 202214311
Jun 20220456
Jul 20221678
Aug 20223286
Sep 20221238
Oct 202204910
Nov 20222384
Dec 20222362
Jan 20233425
Feb 202314510
Mar 202306728
Apr 20232447
May 20231224
Jun 20231174
Jul 20230277
Aug 20232197
Sep 202313812
Oct 20233585
Nov 20230227
Dec 2023612012
Jan 2024101135
Feb 20246598
Mar 202465139
Apr 202456512
Total1183943786